- 同
- Benadryl
- 関
- Diphenhydramine
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/10/05 10:17:23」(JST)
[Wiki en表示]
Benadryl (diphenhydramine) is a brand name allergy medicine marketed over-the-counter by Johnson & Johnson subsidiary McNeil Consumer Healthcare. Prior to 2007, Benadryl was marketed by Pfizer Consumer Healthcare.[1][2] Benadryl was invented by George Rieveschl and first made publicly available through prescription in 1946.[3]
Benadryl contains one of several antihistamines and is used for the temporary relief of seasonal and perennial allergy symptoms. Benadryl is available for oral or topical use.
In the United States and Canada, Benadryl products contain the first-generation antihistamine diphenhydramine. In the United Kingdom, Benadryl products contain either the second-generation non-sedating antihistamine acrivastine (marketed as Benadryl Allergy Relief, with a suggested efficacy duration of eight hours) or the long acting antihistamine cetirizine (marketed as Benadryl One a Day Relief). Benadryl products are marketed in Australia and New Zealand by Johnson & Johnson Pacific. They are marketed as cough medicines and do not contain any antihistamine. Each 5 mL of Benadryl Chesty Cough & Nasal Congestion contains 100 mg of guaiphenesin (an expectorant) and 30 mg of pseudoephedrine hydrochloride as the active ingredients [4]
References
- ^ "Johnson & Johnson to Acquire Pfizer Consumer Healthcare" (Press release). Johnson & Johnson. June 26, 2006. http://www.investor.jnj.com/releaseDetail.cfm?releaseid=201875. Retrieved November 19, 2009.
- ^ "Johnson & Johnson Completes Acquisition Of Pfizer Consumer Healthcare" (Press release). Johnson & Johnson. December 20, 2006. http://www.investor.jnj.com/releaseDetail.cfm?releaseid=223093. Retrieved November 19, 2009.
- ^ Ohio History central: Benadryl; accessed Jan. 5, 2011
- ^ Benadryl for the Family Chesty Cough & Nasal Congestion Oral Liquid ; accessed Oct. 13, 2011
- "Benadryl (Diphenhydramine) Drug Information". RXList. 2009. http://www.rxlist.com/benadryl-drug.htm. Retrieved March 6, 2009.
- "Drugs and Human Performance Fact Sheets: Diphenhydramine". National Highway Traffic and Safety Administration. May 6, 2004. http://www.nhtsa.dot.gov/people/injury/research/job185drugs/diphenhydramine.htm. Retrieved March 6, 2009.
External links
- Official UK product website
- Official US product website
- Official Australia & New Zealand product website
Johnson & Johnson
|
|
CEOs and presidents |
Current: William C. Weldon, Chairman & CEO
- Robert Wood Johnson I
- James Wood Johnson
- Robert Wood Johnson II
- Robert Wood Johnson III
- Philip B. Hofmann
- Richard B. Sellars
- James E. Burke
- Ralph S. Larsen
|
|
Selected subsidiaries |
- ALZA Corporation
- Centocor
- Cilag
- Crucell
- DePuy, Inc.
- Ethicon Endo-Surgery, Inc.
- Ethicon, Inc.
- Independence Technology, LLC
- J&J PRD
- Janssen Pharmaceutica
- LifeScan
- McNeil Consumer & Specialty Pharmaceuticals
- McNeil Nutritionals
- Ortho-McNeil Pharmaceutical
- Ortho-Neutrogena
- Penaten
- Tibotec
|
|
Major brands |
- Acuvue
- Aveeno
- Band-Aid
- Benadryl
- Carefree
- Clean & Clear
- Johnson's Baby
- K-Y
- Neosporin
- Neutrogena
- OneTouch
- Rembrandt
- Rolaids
- Stayfree
- Sudafed
- Tylenol
|
|
- Annual revenue: $63.75 billion USD 4.3% (FY 2008)
- Annual net income: $12.95 billion USD 22.4% (FY 2008)
- Employees: 118,700
- Stock symbol: NYSE: JNJ
- Website: www.jnj.com
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- A multi-omic approach to elucidate low-dose effects of xenobiotics in zebrafish (Danio rerio) larvae.
- Huang SS1, Benskin JP2, Veldhoen N3, Chandramouli B4, Butler H4, Helbing CC3, Cosgrove JR4.
- Aquatic toxicology (Amsterdam, Netherlands).Aquat Toxicol.2017 Jan;182:102-112. doi: 10.1016/j.aquatox.2016.11.016. Epub 2016 Nov 18.
- Regulatory-approved toxicity assays such as the OECD Fish Embryo Toxicity Assay (TG236) allow correlation of chemical exposure to adverse morphological phenotypes. However, these assays are ineffective in assessing sub-lethal (i.e. low-dose) effects, or differentiating between similar phenotypes ind
- PMID 27886581
- Premedication Use Before Infliximab Administration: A Cross-sectional Analysis.
- Picoraro J1, Winberry G, Siegel CA, El-Matary W, Moses J, Grossman A, Park KT.
- Inflammatory bowel diseases.Inflamm Bowel Dis.2017 Jan;23(1):174-180. doi: 10.1097/MIB.0000000000001002.
- BACKGROUND: Premedications are commonly given to patients with inflammatory bowel disease before intravenous infliximab administration. We aimed to (1) describe practice variability; and (2) determine clinician rationale for premedicating patients with inflammatory bowel disease before infliximab ad
- PMID 28002131
- Co-amorphous Formation Induced by Combination of Tranilast and Diphenhydramine Hydrochloride.
- Ueda H1, Kadota K2, Imono M1, Ito T2, Kunita A2, Tozuka Y3.
- Journal of pharmaceutical sciences.J Pharm Sci.2017 Jan;106(1):123-128. doi: 10.1016/j.xphs.2016.07.009. Epub 2016 Aug 15.
- In this study, we investigated the formation of a co-amorphous system of tranilast (TRL) and diphenhydramine hydrochloride (DPH), which are drugs used for treating allergies and inflammation. The crystallization from undercooled melts of the drugs and drug mixtures was evaluated by thermal analysis.
- PMID 27539557
Japanese Journal
- SARTストレス(反復寒冷ストレス)マウスの摘出小腸におけるアセチルコリン反応性減弱についての一考察
Related Links
- BENADRYL® Allergy and Anti-Itch medications provide effective relief for your allergy and itch symptoms.
- Benadryl (diphenhydramine) is a brand name antihistamine (allergy medicine) marketed over-the-counter by Johnson & Johnson subsidiary McNeil Consumer Healthcare. Prior to 2007, Benadryl was marketed by Pfizer Consumer Healthcare.
Related Pictures
★リンクテーブル★
[★]
ジフェンヒドラミン